Status:
COMPLETED
AVANTI - Avelox® in Acute Exacerbations of chroNic bronchiTIs
Lead Sponsor:
Bayer
Conditions:
Bronchitis, Chronic
Eligibility:
All Genders
35+ years
Brief Summary
The objective of this global non-interventional study is to evaluate the impact of Acute Exacerbation of Chronic Bronchitis(AECB) on the patient and the community as well as the safety and effect of a...
Eligibility Criteria
Inclusion
- Patients at least 35 years of age with a diagnosis of Acute Exacerbation of Chronic Bronchitis (AECB) and decision taken by the investigator to treat with Avelox.
Exclusion
- Exclusion criteria must be read in conjunction with the local product information.
Key Trial Info
Start Date :
April 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2010
Estimated Enrollment :
2672 Patients enrolled
Trial Details
Trial ID
NCT00846911
Start Date
April 1 2008
End Date
April 1 2010
Last Update
July 9 2012
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations, Albania
2
Many Locations, Bosnia and Herzegovina
3
Many Locations, Kazakhstan
4
Many Locations, Moldova